Target intelligence / Profile preview

Matrix Protein M2e-NP Antigen

Molecular classification: Recombinant fusion protein, Antigen

Overview

The Matrix protein M2e-NP antigen is a recombinant fusion protein that combines the extracellular domain of the influenza A virus matrix protein 2 (M2e) with the nucleoprotein (NP). This chimeric antigen is designed to enhance immunogenicity and induce broad, cross-protective immune responses against influenza A viruses.

Mechanism of action

Induces anti-M2e antibodies and T-cell responses via NP-derived epitopes.

Biological functions

Antigen presentationImmune response inductionVaccine development

Disease associations

InfectionInfluenza A virus

Beyond the preview

Go deeper on Matrix Protein M2e-NP Antigen.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Matrix Protein M2e-NP Antigen.

Explore the full profile